Jhandewalas Foods Limited has informed BSE of an upcoming board meeting scheduled for Monday, May 18, 2026, at 12:30 P.M. at the company's registered office located at B-70, 1st Floor, Upasana Tower, Janta Store, Bapu Nagar, Jaipur – 302015, Rajasthan. The intimation has been filed pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The board meeting has been convened to deliberate on several significant matters. The following agenda items are scheduled for consideration:

Director Resignation

The board will also consider the resignation of Mr. Rajat Kasliwal (DIN: 07781908) from the post of Independent Director of the company. The resignation was received on March 12, 2026, and is set to take effect from the closure of business hours on May 18, 2026.

Trading Window Closure

In continuation of its earlier intimation on the Closure of Trading Window dated March 31, 2026, Jhandewalas Foods has informed that the trading window for trading in the shares of the company has been closed for all Designated Persons, their immediate relatives, and other connected persons with effect from April 1, 2026. The trading window will remain closed until 48 hours after the declaration of the audited financial results for the half year and full year ended March 31, 2026.

The intimation was signed by Raakesh B Kulwal, Managing Director (DIN: 00615150), on May 11, 2026.

Jhandewalas Foods Limited has filed its quarterly compliance statement with BSE Limited, confirming no deviation in the utilization of funds raised through preferential issue for the quarter ended March 31, 2026. The statement was submitted on April 14, 2026, by Managing Director Raakesh B Kulwal in accordance with SEBI regulations.

Fund Raising Details

The company raised funds through preferential issues on two separate occasions, generating significant capital for its operations.

Regulatory Compliance

The statement was filed pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019. The company confirmed that there was no deviation or variation in the use of proceeds from the preferential issue compared to the originally stated objectives.

Fund Utilization Status

The compliance document reveals complete adherence to the original fund allocation plan:

• Deviation Status: No deviation reported
• Shareholder Approval Required: Not applicable
• Audit Committee Comments: Not applicable
• Auditor Comments: Not applicable
• Fund Utilization: As per original objects

Corporate Governance

The statement emphasizes the company's commitment to transparent financial practices and regulatory compliance. Managing Director Raakesh B Kulwal (DIN: 00615150) digitally signed the document, ensuring proper authorization and accountability for the fund utilization report.

The company's adherence to SEBI guidelines demonstrates strong corporate governance practices, particularly in maintaining transparency regarding the use of funds raised from investors. This compliance filing reinforces investor confidence by confirming that the capital raised through preferential issues has been deployed according to the disclosed objectives without any deviations or modifications.